Drug‐Disease Interaction and Time‐Dependent Population Pharmacokinetics of Isatuximab in Relapsed/Refractory Multiple Myeloma Patients

by Jean‐Baptiste Fau, Raouf El‐Cheikh, Claire Brillac, Kimiko Koiwai, Nathalie Mace, Frank Campana, Dorothee Semiond, Laurent Nguyen
Published 2020-11-01

Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

by Paul G. Richardson, Thierry Facon, William I. Bensinger, Xavier Leleu, Frank Campana, Sandrine Macé, Marielle Chiron, Helgi van de Velde, Joseph Mikhael
Published 2021-03-01

Addition of amifostine to the CHOP regimen in elderly patients with aggressive non-Hodgkin lymphoma: a phase II trial showing reduction in toxicity without altering long-term survi...

by Henry L. Gómez, César Samanéz, Frank Campana, Silvia P. Neciosup, Luis Vera, Luis Casanova, Jorge Leon, Claudio Flores, Fernando Hurtado de Mendoza, Carlos A. Casteñeda, Joseph A. Pinto, Carlos S. Vallejos
Published 2012-07-01